Menactra Launch Slated For March On Heels Of Broad CDC Recommendations
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory Committee on Immunization Practices recommends routine meningococcal vaccination for adolescents ages 11-12, those entering high school and college freshmen living in dorms. Panel acknowledges that broad recommendations could lead to supply constraints, Sanofi says.
You may also be interested in...
Menactra Supply Shortage Will Be Resolved By Fall, FDA Says
CDC recommends Sanofi Pasteur’s oral meningococcal disease vaccine Menomune as an “acceptable alternative” to the firm’s intramuscular vaccine.
Menactra Supply Shortage Will Be Resolved By Fall, FDA Says
CDC recommends Sanofi Pasteur’s oral meningococcal disease vaccine Menomune as an “acceptable alternative” to the firm’s intramuscular vaccine.
Menactra Pricing Will Be In Line With Wyeth's Prevnar, Sanofi-Aventis Says
Sanofi-Aventis will price its meningococcal conjugate vaccine Menactra in line with Wyeth's pneumococcal vaccine Prevnar